Newpath Partners — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
AveloJan 2025SEC filingmedium confidence
Travel & HospitalityHouston, US
Andrew C. Levy(Chief Executive Officer)Hunter Keay(Chief Financial Officer)Robert Ashcroft(Director)Miguel Heras(Director)
BoardWill Snellings(Director)Thomas Mahr(Director)
Board seatThomas Cahill· per SEC Form D · $40M raise · filed Jan 2025
Co-investorsMorgan Stanley
Rinascera TherapeuticsSep 2025SEC filingmedium confidence
BiotechBoston, US
Nichola Eliovits(Executive Officer, Director)Max Dawson(Executive Officer)Karl Beutner(Executive Officer, Director)
Board seatDaniel Yadegar· per SEC Form D · $2.5M raise · filed Oct 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.